Basic Information
Basic information for SOX9-AS1-239-13aa-2
Peptide Name SOX9-AS1-239-13aa-2
Genome Position chr17:72076462-72076500[-]
Species Human
Peptide Sequence MKNEWNSTGLEQS
Peptide Length 13
Unique No (SOX9-AS1-204-13aa-1,SOX9-AS1-220-13aa-2,SOX9-AS1-223-13aa-2,SOX9-AS1-225-13aa-2,SOX9-AS1-228-13aa-1,SOX9-AS1-229-13aa-2,SOX9-AS1-231-13aa-2,SOX9-AS1-232-13aa-1,SOX9-AS1-234-13aa-1,SOX9-AS1-237-13aa-1)
Grand Average of Hydropathicity -1.4846
Relative Molecular Mass 1739.85
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000671151;SOX9-AS1-239
Transcript Length 1258
Coding Ability 0.6407
DNA Sequence Corresponding to Peptide ATGAAGAATGAGTGGAATTCCACAGGATTGGAGCAGTCT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :